Physician profile
Arash Arabi
NPI 1447219654
$1,375.13
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $260 · 2021: $518 · 2022: $129 · 2023: $131 · 2024: $49.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $179.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $386.04 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Smith+Nephew, INC. | $327.09 | 2019-2024 | Grafix Pl |
| Abbvie INC. | $137.36 | 2021 | |
| Melinta Therapeutics, LLC | $129.37 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $93.20 | 2020-2021 | |
| Allergan, INC. | $67.95 | 2019 | |
| Organogenesis INC. | $67.82 | 2019 | |
| Amgen INC. | $33.83 | 2024 | Krystexxa |
| Osiris Therapeutics INC. | $25.59 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $25.28 | 2020-2021 | |
| Misonix INC | $16.25 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.08 | 2020 | |
| Horizon Therapeutics Plc | $14.31 | 2020 | |
| Medline Industries LP | $13.44 | 2019 | |
| Integra Lifesciences Corporation | $11.44 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arash Arabi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.